Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Zynex Inc (ZYXI) Insider Trading Activity
Healthcare • Medical Distribution • 1,100 employees
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Total Value
-$771,895.41
Total Shares
-49,687
Average Trade Value
-$24,121.73
Most Active Insider
Moorhead Daniel J
Total Activity: $370,462
Largest Single Transaction
$134,504
by Lucsok Anna on Aug 6, 2024
30-Day Activity
3 Transactions
Volume: 9,879 shares
Value: $119,539
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Chief Financial Officer
|
Dec 5, 2024 | 4,879 | $38,739 | 35,561 (-13.7%) | Payment of Exercise Price | |
Chief Financial Officer
|
Dec 5, 2024 | 5,000 | $0 | 66,557 (+7.5%) | Grant | |
Chief Financial Officer
|
Dec 2, 2024 | 10,000 | $80,800 | 35,190 (-28.4%) | Sale | |
President, CEO and Chairman
|
Nov 14, 2024 | 2,000 | $16,180 | 14,603,662 (-0.0%) | Sale | |
President, CEO and Chairman
|
Nov 13, 2024 | 2,000 | $16,740 | 14,605,662 (-0.0%) | Sale | |
President, CEO and Chairman
|
Nov 12, 2024 | 2,000 | $18,480 | 14,607,662 (-0.0%) | Sale | |
President, CEO and Chairman
|
Nov 11, 2024 | 2,000 | $18,180 | 14,609,662 (-0.0%) | Sale | |
President, CEO and Chairman
|
Nov 8, 2024 | 2,000 | $17,540 | 14,611,662 (-0.0%) | Sale | |
President, CEO and Chairman
|
Nov 7, 2024 | 2,000 | $18,340 | 14,613,662 (-0.0%) | Sale | |
President, CEO and Chairman
|
Nov 6, 2024 | 2,000 | $17,640 | 14,615,662 (-0.0%) | Sale | |
President, CEO and Chairman
|
Nov 5, 2024 | 2,000 | $16,100 | 14,617,662 (-0.0%) | Sale | |
President, CEO and Chairman
|
Nov 4, 2024 | 2,000 | $17,340 | 14,619,350 (-0.0%) | Sale | |
President, CEO and Chairman
|
Nov 1, 2024 | 2,000 | $17,260 | 14,621,350 (-0.0%) | Sale | |
Chief Financial Officer
|
Nov 1, 2024 | 10,000 | $85,900 | 44,878 (-22.3%) | Sale | |
President, CEO and Chairman
|
Oct 31, 2024 | 2,000 | $17,640 | 14,623,350 (-0.0%) | Sale | |
President, CEO and Chairman
|
Oct 30, 2024 | 2,000 | $17,840 | 14,625,350 (-0.0%) | Sale | |
Chief Financial Officer
|
Oct 29, 2024 | 6,912 | $0 | 74,696 (+9.3%) | Grant | |
Chief Operating Officer
|
Oct 29, 2024 | 2,764 | $0 | 74,101 (+3.7%) | Grant | |
President, CEO and Chairman
|
Oct 29, 2024 | 6,912 | $0 | 21,196 (+32.6%) | Grant | |
Chief Operating Officer
|
Oct 27, 2024 | 5,000 | $0 | 72,014 (+6.9%) | Grant | |
Chief Operating Officer
|
Oct 27, 2024 | 2,323 | $21,186 | 22,036 (-10.5%) | Payment of Exercise Price | |
Chief Financial Officer
|
Sep 5, 2024 | 5,000 | $0 | 71,363 (+7.0%) | Grant | |
Chief Financial Officer
|
Sep 5, 2024 | 5,250 | $41,423 | 50,634 (-10.4%) | Payment of Exercise Price | |
Chief Operating Officer
|
Aug 7, 2024 | 8,083 | $64,906 | 16,980 (-47.6%) | Sale | |
Chief Operating Officer
|
Aug 6, 2024 | 16,792 | $134,504 | 25,063 (-67.0%) | Sale | |
Chief Operating Officer
|
Jul 30, 2024 | 1,104 | $0 | 74,918 (+1.5%) | Grant | |
Chief Financial Officer
|
Jul 30, 2024 | 2,760 | $0 | 75,676 (+3.6%) | Grant | |
President, CEO and Chairman
|
Jul 30, 2024 | 2,760 | $0 | 19,176 (+14.4%) | Grant | |
Chief Financial Officer
|
Jul 30, 2024 | 15,000 | $123,600 | 46,571 (-32.2%) | Sale | |
Jul 29, 2024 | 7,000 | $58,233 | 72,000 (+9.7%) | Purchase | ||
Chief Operating Officer
|
Jul 29, 2024 | 3,572 | $29,790 | 41,201 (-8.7%) | Payment of Exercise Price | |
Chief Operating Officer
|
Jul 27, 2024 | 5,000 | $0 | 74,620 (+6.7%) | Grant |